Automated QT measurement and application to detection of moxifloxacin-induced changes

Annals of Noninvasive Electrocardiology

Volumn 14, Issue SUPPL. 1, 2009, Pages

  Mortara, David W ^a  

^a Mortara Instrument   (United States)

Author keywords

12 lead; Beat to beat; Holter; Moxifloxacin; QT

Indexed keywords

MOXIFLOXACIN; PLACEBO;

ALGORITHM; ARTICLE; AUTOMATION; DATA BASE; HEART FAILURE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; QT PROLONGATION; T WAVE;

ALGORITHMS; AZA COMPOUNDS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE; HUMANS; LONG QT SYNDROME; MALE; QUINOLINES; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 58449097617     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2008.00262.x     Document Type: Article

References (4)

1. Glantz S. Primer of Biostatistics, 6th Edition, McGraw Hill, 2005, pp. 77 80.
2. Coumel P, Fayn J, Maison-Blanche P, et al. Clinical relevance of assessing QT dynamicity in Holter recordings. J Electrocardiogr 1994 27 : 62 66.
3. Hnatkova K, Gang Y, Batchvarov V, et al. Precision of QT measurement by advanced electrocardiographic equipment. Pace 2006 29 : 1277 1284.
4. Tavazzi L, Tognoni G, Franzosi MG, et al., for the GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: A large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004 6 : 635 641.